NeueHealth (NYSE:NEUE) Trading Up 1.3% – Still a Buy?

NeueHealth, Inc. (NYSE:NEUE) traded up 1.3% on Tuesday . The company traded as high as $6.65 and last traded at $6.58. 2,225 shares were traded during trading, a decline of 89% from the average session volume of 20,469 shares. The stock had previously closed at $6.49.

NeueHealth Stock Performance

The company has a fifty day simple moving average of $6.61 and a two-hundred day simple moving average of $6.22. The firm has a market capitalization of $54.48 million, a PE ratio of -0.13 and a beta of 0.54.

NeueHealth (NYSE:NEUE) last released its quarterly earnings data on Thursday, March 20th. The company reported ($7.41) earnings per share for the quarter, missing analysts’ consensus estimates of ($2.29) by ($5.12). The business had revenue of $232.64 million during the quarter, compared to analysts’ expectations of $261.80 million. NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%. On average, equities analysts anticipate that NeueHealth, Inc. will post -9.13 earnings per share for the current fiscal year.

Insider Activity at NeueHealth

In related news, CEO George Lawrence Mikan III sold 13,180 shares of the firm’s stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total transaction of $91,337.40. Following the sale, the chief executive officer now owns 297,790 shares of the company’s stock, valued at $2,063,684.70. This trade represents a 4.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jay Matushak sold 4,448 shares of NeueHealth stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the transaction, the chief financial officer now owns 41,592 shares in the company, valued at $280,330.08. This trade represents a 9.66 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 68,178 shares of company stock valued at $467,763 over the last ninety days. 64.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On NeueHealth

An institutional investor recently bought a new position in NeueHealth stock. Virtu Financial LLC purchased a new position in shares of NeueHealth, Inc. (NYSE:NEUE) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,232 shares of the company’s stock, valued at approximately $76,000. Virtu Financial LLC owned about 0.12% of NeueHealth as of its most recent filing with the Securities & Exchange Commission. 63.88% of the stock is owned by hedge funds and other institutional investors.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.